BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic
BioFactura, Inc. today announced a contract option activation of over $13 million by the Biomedical Advanced Research and Development Authority ...
BioFactura, Inc. today announced a contract option activation of over $13 million by the Biomedical Advanced Research and Development Authority ...
